• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

6th Joint Scientific Meeting HAT Platform – EANETT

14-16 October 2024

Conakry, Guinea

Lire en Français

The theme of the 6th Joint Scientific Meeting HAT Platform-EANETT is ‘Bringing innovation to contribute to the interruption of HAT transmission by 2030’.

This innovation-focused scientific meeting is being organized to contribute to the World Health Organization’s roadmap for interrupting HAT transmission by 2030 and will provide an opportunity for national programmes and researchers to share their results and control efforts to date, so that HAT control programmes can use them to improve their national strategies and policies.

Download the full agenda

Roundtable

Innovative WHO strategies for eliminating and interrupting HAT transmission by 2030 and research perspectives

Date: Monday, 14 October 2024
Time: 9:00 – 12:00

Chair: Mohamed Cissé, Chairman of Scientific Committee
Deputy chair: Olaf Valverde, DNDi and Mamadou Saliou Sow

Efforts and advances towards interruption of HAT transmission: A Situational Overview: Keynote Address
Gegardo Prieto
Summary of HAT epidemiological situation and needs for research
Mamadou Camara, Oumou Camara, Makana Don Paolo, Charles Wamboga
HAT DNDi program progress and evolution in the path to elimination
Stéphane Hugonnet, NTD HAT-Filarial-Chagas Cluster Director, DNDi

Session

Innovation in screening strategies, community engagement, diagnostic options, treatment and pharmacovigilance

Date: Tuesday, 15 October 2024

Active search strategy for cases of human African trypanosomiasis in non-endemic villages 10 years ago by the management team of the rural health zone of bagata, Kwilu province in the DRC
Matthieu Nkieri, Co-investigateur FEX09 & OXA 02 HGR BAGATA, DNDi
Safety of acoziborole in people with T.b. gambiense-confirmed HAT and not confirmed by parasitological testing: A multicenter, randomized, double-blind, placebo-controlled study
Adeline Prêtre, Clinical Project Manager, DNDi


6ème Réunion Scientifique Conjointe Plateforme THA-EANETT

Le thème de le 6ème Réunion Scientifique Conjointe Plateforme THA-EANETT est ‘Apport de l’innovation pour contribuer à l’interruption de la transmission de la THA d’ici 2030’.

Axée sur l’innovation, cette réunion scientifique est organisée pour contribuer à la feuille de route de l’Organisation Mondiale de la Santé dont l’objectif est l’interruption de la transmission de la THA d’içi 2030. Elle va donner l’occasion aux programmes nationaux et aux chercheurs de partager leurs résultats et leurs efforts de contrôle réalisés à ce jour afin que les programmes de lutte contre la THA puissent s’en servir pour améliorer leurs stratégies et leurs politiques nationales.

Télécharger le programme

Sleeping sickness

Other events

Loading...
15-20 June 2025

Kigali, Rwanda

Twelfth EDCTP Forum

15-18 June 2025

Manila, Philippines

8th Asia Dengue Summit

22 May 2025

Online event

MSF Scientific Days

21 May 2025, 9-10:30 AM

Geneva, Switzerland

Scaling impact: Climate & health solutions that drive change

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License